Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit - Pharming (NASDAQ:PHAR)

Summary by Benzinga
Leiden, the Netherlands, December 8, 2025: Pharming Group N.V. ("Pharming") (NASDAQ:PHAR) today announced its participation in the Oppenheimer Movers in Rare Disease Summit on December 11, 2025 in New York City. This invitation-only event brings together innovative companies and investors focused on rare diseases. Anurag Relan, M.D., Chief Medical Officer of Pharming, will participate in a fireside chat focused on the hereditary angioedema (HAE)…

1 Articles

BenzingaBenzinga
Center

Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit - Pharming (NASDAQ:PHAR)

Leiden, the Netherlands, December 8, 2025: Pharming Group N.V. ("Pharming") (NASDAQ:PHAR) today announced its participation in the Oppenheimer Movers in Rare Disease Summit on December 11, 2025 in New York City. This invitation-only event brings together innovative companies and investors focused on rare diseases. Anurag Relan, M.D., Chief Medical Officer of Pharming, will participate in a fireside chat focused on the hereditary angioedema (HAE)…

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Monday, December 8, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Leiden icon

Leiden

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal